An apple a day (used to) keep the doctor away
Dear All: OK … enough with bad news, at least for today. In today’s edition of XKCD (link), we learn about resistance to apples and
Dear All: OK … enough with bad news, at least for today. In today’s edition of XKCD (link), we learn about resistance to apples and
Aside: Please look closely at the forward calendar. In addition to two new webinars from GARDP’s REVIVE project, there is a meeting in Thailand in December
Dear All: The new Novo REPAIR impact fund ($165m over 5 years for antibacterials) is now open for applications — see the template at this link.
Dear All: It was a HUGE day at the Pew Charitable Trusts today! First, Commissioner Scott Gottleib gave a superb and very exciting speech. You can
Dear All: I’ve written before about BARDA’s DRIVe initiative (Division of Research Innovation and Ventures, launched June 2018) that seeks to develop countermeasures for chemical, biological, radiological, and
Long note alert— apologies! Get a cup of coffee and settle in… Dear All: My 22 Apr 2019 note entitled Scary, Scarier, Scariest: Achaogen / FT
There is a follow-up to this note. Go here to read it. Dear All: I don’t like writing about doom and gloom, but a sequence of events
Dear All: I trust you are now home after ECCMID in Madrid … it was an excellent meeting. Two new funding opportunities have recently crossed
Dear All, Two very brief notes today… First, Pew Trusts continues to work to provide ways to understand the antibiotic pipeline. Building on their ongoing surveys
Dear All: Apologies for inundating with updates … the last few days have been very data rich! In case you missed it, McCann et al. (Env Internat,